cln2family.com

CLN2 disease is a rare genetic disorder that primarily affects children, resulting from mutations in the CLN2/TPP1 gene. This condition falls under the category of neuronal ceroid lipofuscinoses (NCL), collectively known as Batten disease. Symptoms typically emerge between the ages of 2 and 4, and affected children experience significant developmental challenges such as language delays, seizures, and visual impairment due to the improper functioning of the TPP1 enzyme. This malfunction leads to harmful material accumulation in the brain and eyes, impairing cellular function over time.

Parents of affected children are often carriers of the genetic mutation, and inheritance follows an autosomal recessive pattern. Diagnosis can be confirmed through genetic or enzyme testing. Organizations like the Batten Disease Support and Research Association (BDSRA) are dedicated to funding research for treatments and providing essential support for families impacted by CLN2 disease. By raising awareness and keeping the community informed, these efforts aim to improve the lives of those confronting this challenging condition.